BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 19565045)

  • 1. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
    Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
    Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological and immunohistochemical study of hepatic stellate cells in patients with viral C chronic liver disease.
    Ionescu AG; Streba LA; Vere CC; Ciurea ME; Streba CT; Ionescu M; Comănescu M; Irimia E; Rogoveanu O
    Rom J Morphol Embryol; 2013; 54(4):983-91. PubMed ID: 24398994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.
    Gonzalez SA; Fiel MI; Sauk J; Canchis PW; Liu RC; Chiriboga L; Yee HT; Jacobson IM; Talal AH
    J Viral Hepat; 2009 Feb; 16(2):141-8. PubMed ID: 19175868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy.
    Khan MA; Poulos JE; Brunt EM; Li L; Solomon H; Britton RS; Bacon BR; Di Bisceglie AM
    Hepatogastroenterology; 2001; 48(37):212-5. PubMed ID: 11268968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between plasma cells and hepatic stellate cells in autoimmune hepatitis.
    Brandão DF; Ramalho FS; Martinelli AL; Zucoloto S; Ramalho LN
    Pathol Res Pract; 2010 Dec; 206(12):800-4. PubMed ID: 20926203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
    Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
    Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
    Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW
    Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of stellate cells in patients with chronic viral hepatitis C genotype 1.
    Săndulescu L; Rogoveanu I; Ciurea T; Comănescu MV; Streba CT; Ionescu AG; Oproaica A; Ene M
    Rom J Morphol Embryol; 2011; 52(1):137-43. PubMed ID: 21424045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission.
    Maia JM; Maranhão Hde S; Sena LV; Rocha LR; Medeiros IA; Ramos AM
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):264-9. PubMed ID: 20009940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis.
    Akyol G; Erdem O; Yilmaz G
    Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study.
    Akpolat N; Yahsi S; Godekmerdan A; Yalniz M; Demirbag K
    Histopathology; 2005 Sep; 47(3):276-80. PubMed ID: 16115228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic stellate cells in hepatitis C patients: relationship with the development of interstitial fibrosis in renal allografts.
    Ozdemir BH; Bilezikçi B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2838-40. PubMed ID: 19765451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GFAP expression in the liver as an early marker of stellate cells activation.
    Morini S; Carotti S; Carpino G; Franchitto A; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2005; 110(4):193-207. PubMed ID: 16536051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C.
    Cisneros L; Londoño MC; Blasco C; Bataller R; Miquel R; Bruguera M; Ginès P; Rimola A
    Liver Transpl; 2007 Jul; 13(7):1017-27. PubMed ID: 17600343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.
    Guido M; Rugge M; Leandro G; Fiel IM; Thung SN
    Hepatology; 1997 Aug; 26(2):310-4. PubMed ID: 9252139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic expression of c-Myb in chronic human liver disease.
    Kitada T; Seki S; Nakatani K; Kawada N; Kuroki T; Monna T
    Hepatology; 1997 Dec; 26(6):1506-12. PubMed ID: 9397991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.
    Leicester KL; Olynyk JK; Brunt EM; Britton RS; Bacon BR
    Liver Int; 2006 Jun; 26(5):559-65. PubMed ID: 16762000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
    Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
    Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.